PREDICTING THE OUTCOMES OF COMBINATION THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C USING ARTIFICIAL NEURAL NETWORK

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

SARGOLZAEE AVAL FOROUGH; BEHNAZ NAZANIN; RAOUFY MOHAMAD REZA; ALAVIAN SEYED MOAYED

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Hepatitis Monthly Year:2014 | Volume:14 | Issue:6 Page(s): 0-0

Download Full-Text

View:

338

Download:

164

Cites:

Information Journal Paper

Title

PREDICTING THE OUTCOMES OF COMBINATION THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C USING ARTIFICIAL NEURAL NETWORK

Author(s)

SARGOLZAEE AVAL FOROUGH | BEHNAZ NAZANIN | RAOUFY MOHAMAD REZA | ALAVIAN SEYED MOAYED | Issue Writer Certificate

Keywords

CHOLESTEROL

HEPATITIS C

CHRONIC

HEMOGLOBIN

IL28B PROTEIN

HUMAN

PEGINTERFERON ALFA-2B

RIBAVIRIN

Abstract

Background: Treatment with Peginterferon Alpha-2b plus RIBAVIRIN is the current standard therapy for CHRONIC HEPATITIS C (CHC). However, many host related and viral parameters are associated with different outcomes of combination therapy.Objectives: The aim of this study was to develop an artificial neural network (ANN) model to predetermine individual responses to therapy based on patient’s demographics and laboratory data.Patients and Methods: This case-control study was conducted in Tehran, Iran, on 139 patients divided into sustained virologic response (SVR) (n=50), relapse (n=50) and non-response (n=39) groups according to their response to combination therapy for 48 weeks. The ANN was trained 300 times (epochs) using clinical data. To test the ANN performance, the part of data that was selected randomly and not used in training process was entered to the ANN and the outputs were compared with real data.Results: HEMOGLOBIN (P<0.001), CHOLESTEROL (P=0.001) and IL-28b genotype (P=0.002) values had significant differences between the three groups. Significant predictive factor(s) for each group were HEMOGLOBIN for SVR (OR: 1.517; 95% CI: 1.233-1.868; P<0.001), IL-28b genotype for relapse (OR: 0.577; 95% CI: 0.339-0.981; P=0.041) and HEMOGLOBIN (OR: 0.824; 95% CI: 0.693-0.980; P=0.017) and IL-28b genotype (OR: 2.584; 95% CI: 1.430-4.668; P=0.001) for non-response. The accuracy of ANN to predict SVR, relapse and non-response were 93%, 90%, and 90%, respectively.Conclusions: Using baseline laboratory data and host characteristics, ANN has been shown as an accurate model to predict treatment outcome, which can lead to appropriate decision making and decrease the frequency of ineffective treatment in patients with CHRONIC HEPATITIS C virus (HCV) infection.

Cites

A COMPREHENSIVE LONG-TERM PROGNOSIS OF CHRONIC HEPATITIS C PATIENTS WITH ANTIVIRAL THERAPY: A META-ANALYSIS OF STUDIES FROM 2008 TO 2014

References

No record.

Cite

APA: Copy

SARGOLZAEE AVAL, FOROUGH, BEHNAZ, NAZANIN, RAOUFY, MOHAMAD REZA, & ALAVIAN, SEYED MOAYED. (2014). PREDICTING THE OUTCOMES OF COMBINATION THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C USING ARTIFICIAL NEURAL NETWORK. HEPATITIS MONTHLY, 14(6), 0-0. SID. https://sid.ir/paper/306641/en

Vancouver: Copy

SARGOLZAEE AVAL FOROUGH, BEHNAZ NAZANIN, RAOUFY MOHAMAD REZA, ALAVIAN SEYED MOAYED. PREDICTING THE OUTCOMES OF COMBINATION THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C USING ARTIFICIAL NEURAL NETWORK. HEPATITIS MONTHLY[Internet]. 2014;14(6):0-0. Available from: https://sid.ir/paper/306641/en

IEEE: Copy

FOROUGH SARGOLZAEE AVAL, NAZANIN BEHNAZ, MOHAMAD REZA RAOUFY, and SEYED MOAYED ALAVIAN, “PREDICTING THE OUTCOMES OF COMBINATION THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C USING ARTIFICIAL NEURAL NETWORK,” HEPATITIS MONTHLY, vol. 14, no. 6, pp. 0–0, 2014, [Online]. Available: https://sid.ir/paper/306641/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops